Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Dunad Therapeutics Enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies
Dunad Therapeutics (“Dunad”), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation […]
Vensica Therapeutics Closes $16 Million Investment Round
Vensica Therapeutics (“Vensica”), a clinical stage biopharmaceutical company, announced that it has closed an investment round […]
SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]
Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer
Muna Therapeutics (“Muna“), pioneering the development of novel, first-in-class small molecule therapeutics for neurodegenerative diseases, […]
Amphista Therapeutics Appoints CBO, Beverley Carr
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts
Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced […]
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
Aktana Acquires Ople.AI’s Machine Learning Automation Technology
Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced […]
Koa Health Bolsters UK Leadership Team Appointing First UK Commercial Director as Business Grows
Koa Health, a digital mental healthcare provider offering personalized mental health solutions backed by science, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more